Racial and ethnic subgroup reporting in diabetes randomized controlled trials published from 2000 to 2020: A survey-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Racial and ethnic subgroup reporting in diabetes randomized controlled trials published from 2000 to 2020: A survey

Published:2022-11-05 Issue:1 Volume:39 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metabolism Res

Author:

Li Guowei¹²,Zhang Jingyi¹,Chen Bo³,Li Likang¹,Thabane Lehana²⁴,Sun Xin⁵

Affiliation:

1. Center for Clinical Epidemiology and Methodology (CCEM) Guangdong Second Provincial General Hospital Guangzhou China

2. Department of Health Research Methods, Evidence, and Impact (HEI) McMaster University Hamilton Ontario Canada

3. Department of Endocrinology Guangdong Second Provincial General Hospital Guangzhou China

4. Faculty of Health Sciences University of Johannesburg Johannesburg South Africa

5. Chinese Evidence‐based Medicine Center and Cochrane China Center West China Hospital Sichuan University Chengdu China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3588

Reference36 articles.

1. Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016

2. Racial/Ethnic Disparities in Diabetes Diagnosis and Glycemic Control Among Women of Reproductive Age

3. Racial/ethnic differences in drug disposition and response: Review of recently approved drugs

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enrollment of Black, Indigenous and People of Color (BIPOC) and female participants in the US diabetes trials spanning 2000 to 2020: A chronological survey;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-07

2. Federally Funded Randomized Controlled Trials Increase Analysis and Reporting of Study Outcomes by Sex, Race, and Ethnicity;Journal of Women's Health;2023-11-06

3. Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3